![Erik Domines](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Erik Domines worked as the General Counsel at Recipharm AB from 2014 to 2018 and at Xbrane Biopharma AB from 2021 to 2023.
He completed his undergraduate degree at the University of Stockholm.
Antiguos cargos conocidos de Erik Domines.
| Empresas | Cargo | Fin |
|---|---|---|
| XBRANE BIOPHARMA AB | Consejero General | 01/07/2023 |
| RECIPHARM AB (PUBL) | Consejero General | 31/12/2018 |
Formación de Erik Domines.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
15
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Recipharm AB
 Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xbrane Biopharma AB
 Xbrane Biopharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilars for s eye diseases | Health Technology |
- Bolsa de valores
- Insiders
- Erik Domines
